Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 31, 2014
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping.
Journal: The oncologist
Published: December 20, 2011
Showing 1-2 of 2
Last Updated: 09/26/2026